BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21519759)

  • 1. [Similarities, differences and agonisms of pleiotropic effects of statins and omega-3 fatty acids].
    Villalobos ME; Sánchez-Muniz FJ; Acín MT; Vaquero MP; Higueras FJ; Bastida S
    Nutr Hosp; 2010; 25(6):889-909. PubMed ID: 21519759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
    Kar S
    Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.
    Adkins Y; Kelley DS
    J Nutr Biochem; 2010 Sep; 21(9):781-92. PubMed ID: 20382009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?
    von Schacky C
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):94-9. PubMed ID: 18301082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of n-3 fatty acids on endothelial function: results from human interventions studies.
    Egert S; Stehle P
    Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):121-31. PubMed ID: 21252652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J
    Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
    Siriwardhana N; Kalupahana NS; Moustaid-Moussa N
    Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates.
    Dominiczak M
    Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.
    Micallef MA; Garg ML
    J Nutr Biochem; 2009 Dec; 20(12):927-39. PubMed ID: 19733044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine lipids: overview "news insights and lipid composition of Lyprinol".
    Sinclair AJ; Murphy KJ; Li D
    Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 (
    Djuricic I; Calder PC
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of altering dietary n-6:n-3 PUFA ratio on cardiovascular risk measures in patients treated with statins: a pilot study.
    Lee SP; Dart AM; Walker KZ; O'Dea K; Chin-Dusting JP; Skilton MR
    Br J Nutr; 2012 Oct; 108(7):1280-5. PubMed ID: 22182482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective.
    Makris GC; Geroulakos G; Makris MC; Mikhailidis DP; Falagas ME
    Expert Opin Investig Drugs; 2010 Jul; 19(7):809-14. PubMed ID: 20470189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of insulin resistance by n-3 polyunsaturated fatty acids.
    Fedor D; Kelley DS
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):138-46. PubMed ID: 19202385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with statins and omega-3 fatty acids.
    Nambi V; Ballantyne CM
    Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.